These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. [Bevacizumab. Progress in cancer therapy by antiangiogenesis]. Krämer I; Lipp HP Med Monatsschr Pharm; 2006 Jul; 29(7):249-54; quiz 255-6. PubMed ID: 16866078 [TBL] [Abstract][Full Text] [Related]
11. Safety of bevacizumab in mild haemophilia B. Lambert C; Deneys V; Pothen D; Hermans C Thromb Haemost; 2008 May; 99(5):963-4. PubMed ID: 18449429 [No Abstract] [Full Text] [Related]
18. Bevacizumab: an angiogenesis inhibitor with efficacy in colorectal and other malignancies. Zondor SD; Medina PJ Ann Pharmacother; 2004; 38(7-8):1258-64. PubMed ID: 15187215 [TBL] [Abstract][Full Text] [Related]
19. The use of bevacizumab for the treatment of colorectal cancer. Beaumont I Int J Palliat Nurs; 2010 Dec; 16(12):576. PubMed ID: 21240099 [No Abstract] [Full Text] [Related]
20. Caution in adding bevacizumab in the adjuvant treatment of breast cancer. Ziogas D; Roukos D Ann Surg Oncol; 2010 Feb; 17(2):653-4; author reply 655-6. PubMed ID: 19888632 [No Abstract] [Full Text] [Related] [Next] [New Search]